betamethasone and sdz glc 756

betamethasone has been researched along with sdz glc 756 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Greiner, B; Laengle, UW; Markstein, R; Roman, D; Schneider, V	1
Cazaubon, C; Laengle, UW; Markstein, R; Roman, D	1

Other Studies

2 other study(ies) available for betamethasone and sdz glc 756

Article	Year
Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in rats. Experimental eye research, 2005, Volume: 80, Issue:6 Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Aqueous Humor; Betamethasone; Dopamine Agents; Eye Proteins; Glaucoma; Injections, Subcutaneous; Lipopolysaccharides; Quinolines; Rats; Rats, Inbred Lew; Timolol; Tumor Necrosis Factor-alpha; Uveitis	2005
Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor alpha release in vitro of activated human monocytic leukemia cells. Japanese journal of ophthalmology, 2009, Volume: 53, Issue:2 Topics: Antihypertensive Agents; Betamethasone; Cell Line, Tumor; Cyclic AMP; Enzyme-Linked Immunosorbent Assay; Glucocorticoids; Humans; Leukemia, Monocytic, Acute; Lipopolysaccharides; Ophthalmic Solutions; Quinolines; Receptors, Dopamine D1; Receptors, Dopamine D2; Tumor Necrosis Factor-alpha	2009

Article

Year

Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in rats.

Experimental eye research, 2005, Volume: 80, Issue:6

Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Aqueous Humor; Betamethasone; Dopamine Agents; Eye Proteins; Glaucoma; Injections, Subcutaneous; Lipopolysaccharides; Quinolines; Rats; Rats, Inbred Lew; Timolol; Tumor Necrosis Factor-alpha; Uveitis

2005

Antiglaucoma drug GLC756 and its effect on cellular cAMP and tumor necrosis factor alpha release in vitro of activated human monocytic leukemia cells.

Japanese journal of ophthalmology, 2009, Volume: 53, Issue:2

Topics: Antihypertensive Agents; Betamethasone; Cell Line, Tumor; Cyclic AMP; Enzyme-Linked Immunosorbent Assay; Glucocorticoids; Humans; Leukemia, Monocytic, Acute; Lipopolysaccharides; Ophthalmic Solutions; Quinolines; Receptors, Dopamine D1; Receptors, Dopamine D2; Tumor Necrosis Factor-alpha

2009